Management of malignancy in HIV infection | Zendy

A. Denton | Zendy; M. F. Spittle | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Management of malignancy in HIV infection

Author(s) -

A. Denton,

M. F. Spittle

Publication year - 1996

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/37.suppl_b.121

Subject(s) - immunosuppression , malignancy , medicine , lymphoma , human immunodeficiency virus (hiv) , opportunistic infection , sarcoma , disease , primary central nervous system lymphoma , immunology , intensive care medicine , viral disease , pathology

The prevalence of HIV-related malignant disease is increasing, probably due to more effective management of opportunistic infection. The most frequent tumours are Kaposi's sarcoma, systemic non-Hodgkin's lymphoma and primary central nervous system lymphoma. Management of these conditions must take into account host indicators of immunosuppression and prognostic outcome in order to minimise treatment associated complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research